在铂纳米颗粒(3纳米)存在的情况下,银纳米颗粒(10纳米)的溶解增强导致细胞毒性增加:通过透射电子显微镜和X射线粉末衍射的机理洞察
Enhanced dissolution of silver nanoparticles (10 nm) in the presence of platinum nanoparticles (3 nm) causes increased cytotoxicity: mechanistic insight transmission electron microscopy and X-ray powder diffraction.
作者信息
Prymak O, Breisch M, Loza K, Heggen M, Köller M, Sengstock C, Epple M
机构信息
Inorganic Chemistry, Center for Nanointegration Duisburg-Essen (CENIDE), University of Duisburg-Essen Universitaetsstr. 5-7 45117 Essen Germany
BG University Hospital Bergmannsheil, Surgical Research, Ruhr University Bochum Bochum Germany.
出版信息
RSC Adv. 2025 Jun 26;15(27):21890-21897. doi: 10.1039/d5ra02579f. eCollection 2025 Jun 23.
The dissolution of silver nanoparticles (10 nm) is strongly enhanced by the presence of platinum nanoparticles (3 nm) in chloride-containing aqueous dispersion. This was shown using X-ray powder diffraction and transmission electron microscopy. Direct contact between the two metals is necessary as shown by transmission electron microscopy. Complete dissolution of silver nanoparticles occurs within about one hour in the presence of potassium chloride as the electrolyte but not in pure water. Thus, the dissolution of silver nanoparticles in aqueous dispersion requires the presence of platinum nanoparticles for polarization as well as the presence of electrolyte ions for charge balancing. After dissolution, the silver ions precipitate as silver chloride. A minor part of silver is taken up by platinum to form a solid solution (alloy). The enhanced release of silver ions in the dispersion of nanoparticles of both metals leads to a decreased viability of human mesenchymal stem cells (hMSC), caused by the cytotoxic effect of silver ions.
在含氯化物的水性分散液中,铂纳米颗粒(3纳米)的存在会显著增强银纳米颗粒(10纳米)的溶解。这通过X射线粉末衍射和透射电子显微镜得以证实。透射电子显微镜显示,两种金属之间的直接接触是必要的。在氯化钾作为电解质存在的情况下,银纳米颗粒在约一小时内完全溶解,但在纯水中则不会。因此,银纳米颗粒在水性分散液中的溶解既需要铂纳米颗粒进行极化,也需要电解质离子进行电荷平衡。溶解后,银离子会沉淀为氯化银。一小部分银会被铂吸收形成固溶体(合金)。两种金属纳米颗粒分散液中银离子的增强释放会导致人间充质干细胞(hMSC)的活力下降,这是由银离子的细胞毒性作用引起的。
相似文献
Nanomaterials (Basel). 2021-8-18
Cochrane Database Syst Rev. 2008-4-16
Cochrane Database Syst Rev. 2018-6-15
Cochrane Database Syst Rev. 2004
Cochrane Database Syst Rev. 2016-8-3
本文引用的文献
Pharmaceuticals (Basel). 2024-8-29
J Biomed Nanotechnol. 2020-6-1
Eur Cell Mater. 2020-6-30
J Mater Chem B. 2014-3-28